Formulated for major depressive disorder and anxiety to manage emotional health and support symptom relief.
Mechanism of Action
Escitalopram is the pure S-enantiomer of citalopram. It highly selectively inhibits the reuptake of serotonin by the presynaptic neuronal membrane, increasing serotonergic activity without affecting other neurotransmitter systems.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
27–32 hours (half-life)
Contraindications
Concurrent use of MAO inhibitors, Concurrent use of pimozide, Hypersensitivity to escitalopram
Information related to Escitalopram is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
